A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
Clinical trial NCT04628143 · COMPLETED
Trial details
- NCT number
- NCT04628143
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2021-04-05
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.